News & Publications

Representation of Luminera Derm in the Sale of its Dermal Business to AbbVie

Representation of Luminera Derm Ltd. and its affiliated companies in a share and asset transaction, pursuant to which Luminera sold its dermal filler portfolio and R&D pipeline to AbbVie Inc. (NYSE: ABBV) unit Allergan Aesthetics, for a consideration of hundreds of millions of dollars. Luminera Derm is an R&D company as well as a manufacturer […]

Raz Tepper & Ziv Schwartz & Sharona Haim Pour - Abramovich & Yuval Peled & Ben Strauss & Audrey Abensur & Moran Friedman | Oct 2020 | Transaction

Labor & Employment Legal Update – Bits & Briefs Series – August 2020

In this “Bits & Briefs” chapter of our special series dedicated to Labor and Employment Law, we discuss certain perspectives of engagement of consultants. Please find the full update here

Shay Teken & Moran Friedman & Raz Tepper & Eran Yaniv | Aug 2020 | Legal Update

Bits & Briefs – Labor Update – January 2020

In our “Bits & Briefs” Special Series dedicated to Israeli Labor and Employment Law, we provide periodic bite-sized updates introducing key provisions of Israeli labor law and their practical implications, particularly from the perspective of businesses looking to operate in, or expand to, Israel. In this update we will cover employees` social rights according to the […]

Moran Friedman & Raz Tepper & Shay Teken & Eran Yaniv | Feb 2020 | Legal Update

Representation of AngioDynamics in the acquisition of Eximo Medical

FBC and DLA Piper represented AngioDynamics Inc., in an acquisition of Eximo Medical Ltd., an Israeli company. The transaction included extensive and sensitive negotiations of the terms and conditions of the acquisition from the various shareholders of Eximo Medical Ltd. and included the purchase of the company’s shares and treatment of the company’s options and […]

Raz Tepper & Yuval Peled & Jonathan Shtang & Moran Friedman & Omri Rachum-Twaig, Dr. | Oct 2019 | Transaction

Representation of Frutarom Industries Ltd. in its Acquisition of Enzymotec Ltd.

FBC represented Frutarom Industries Ltd. in its acquisition of Enzymotec Ltd. (NASD: ENZY), for approximately $210 million, at an equity value of approximately $290 million. Enzymotec is a leading global supplier of specialty lipid-based products and solutions. Prior to the merger, Frutarom had acquired approximately 19% of Enzymotec’s shares and announced its intention to make […]

Avraham Well & Sharon Rosen & Zohar Liss & Ziv Schwartz & Moran Friedman & Hilla Sachs | Jan 2018 | Transaction

FBC advises Credit Suisse NEXT Investors in its investment in Secure Islands

FBC advises Credit Suisse NEXT Investors in its investment in Secure Islands

Ron Sitton & Moran Friedman & Warren Wienburg | Sep 2014 | Transaction

FBC advises Qualcomm in its acquisition of Wilocity for approximately $400M

FBC advises Qualcomm in its acquisition of Wilocity for approximately $400M

Raz Tepper & Moran Friedman | Jul 2014 | Transaction

FBC advises Qualcomm in its acquisition of CSR’s imaging unit for approximately $45M

FBC advises Qualcomm in its acquisition of CSR’s imaging unit for approximately $45M

Raz Tepper & Ronald Lehmann & Amit Dat & Moran Friedman & Ziv Schwartz | Jul 2014 | Transaction